Dysport® study positive in the treatment of NDO
Posted: Tue Mar 18, 2014 1:03 am
Dysport® study positive in the treatment of patients with neurogenic detrusor overactivity
Ipsen announces positive results from phase IIa clinical study of Dysport® in the treatment of patients with Neurogenic Detrusor Overactivity (NDO).
Results show significant decrease in urinary incontinence episodes and improvement in patient quality of life..... Read More - http://www.ms-uk.org/mssymptomsresearch
Ipsen announces positive results from phase IIa clinical study of Dysport® in the treatment of patients with Neurogenic Detrusor Overactivity (NDO).
Results show significant decrease in urinary incontinence episodes and improvement in patient quality of life..... Read More - http://www.ms-uk.org/mssymptomsresearch